{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:08:37Z","timestamp":1772136517102,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":23,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-36242-6","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:15:56Z","timestamp":1768407356000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Utility of prostate-specific antigen derivatives to minimize unnecessary magnetic resonance imaging in patients with prior negative prostate biopsy"],"prefix":"10.1038","volume":"16","author":[{"given":"Sangchul","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoyoung","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Hun","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Il","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hak Jong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakmin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Kyu","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok-Soo","family":"Byun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeongdo","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"36242_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74, 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"36242_CR2","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJMms1914228","volume":"382","author":"HG Welch","year":"2020","unstructured":"Welch, H. G. et al. Reconsidering prostate cancer mortality\u2014The future of PSA screening. N. Engl. J. Med. 382, 1557\u20131563 (2020).","journal-title":"N. Engl. J. Med."},{"key":"36242_CR3","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s41585-022-00638-6","volume":"19","author":"H Van Poppel","year":"2022","unstructured":"Van Poppel, H. et al. Serum PSA-based early detection of prostate cancer in Europe and globally: Past, present and future. Nat. Rev. Urol. 19, 562\u2013572 (2022).","journal-title":"Nat. Rev. Urol."},{"key":"36242_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0022-5347(17)38664-0","volume":"142","author":"KK Hodge","year":"1989","unstructured":"Hodge, K. K. et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J. Urol. 142, 71\u201374 (1989).","journal-title":"J. Urol."},{"key":"36242_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/MOU.0000000000000315","volume":"26","author":"M Perera","year":"2016","unstructured":"Perera, M. et al. Management of men with previous negative prostate biopsy. Curr. Opin. Urol. 26, 481\u2013487 (2016).","journal-title":"Curr. Opin. Urol."},{"issue":"45","key":"36242_CR6","first-page":"e17","volume":"32","author":"Abd-Alazeez","year":"2014","unstructured":"Abd-Alazeez, et al. The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level\u2014can it rule out clinically significant prostate cancer?. Urol. Oncol. 32(45), e17-22 (2014).","journal-title":"Urol. Oncol."},{"key":"36242_CR7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.urolonc.2015.10.014","volume":"34","author":"RC Hutchinson","year":"2016","unstructured":"Hutchinson, R. C. et al. The economic effect of using magnetic resonance imaging and magnetic resonance ultrasound fusion biopsy for prostate cancer diagnosis. Urol. Oncol. 34, 296\u2013302 (2016).","journal-title":"Urol. Oncol."},{"key":"36242_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.urolonc.2021.08.006","volume":"41","author":"EH Kim","year":"2023","unstructured":"Kim, E. H. et al. Should men undergo MRI before prostate biopsy\u2014CON. Urol. Oncol. 41, 92\u201395 (2023).","journal-title":"Urol. Oncol."},{"key":"36242_CR9","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1056\/NEJMoa1910038","volume":"382","author":"M Ahdoot","year":"2020","unstructured":"Ahdoot, M. et al. MRI-targeted, systematic, and combined biopsy for prostate cancer diagnosis. N Engl. J. Med. 382, 917\u2013928 (2020).","journal-title":"N Engl. J. Med."},{"key":"36242_CR10","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.juro.2016.06.079","volume":"196","author":"AB Rosenkrantz","year":"2016","unstructured":"Rosenkrantz, A. B. et al. Prostate magnetic resonance imaging and magnetic resonance imaging targeted biopsy in patients with a prior negative biopsy: A consensus statement by AUA and SAR. J. Urol. 196, 1613\u20131618 (2016).","journal-title":"J. Urol."},{"key":"36242_CR11","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1001\/jamaoncol.2018.4160","volume":"4","author":"SJ Kim","year":"2018","unstructured":"Kim, S. J. et al. Challenges in adopting level 1 evidence for multiparametric magnetic resonance imaging as a biomarker for prostate cancer screening. JAMA Oncol. 4, 1663\u20131664 (2018).","journal-title":"JAMA Oncol."},{"key":"36242_CR12","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1097\/JU.0000000000002491","volume":"208","author":"SM Kawa","year":"2022","unstructured":"Kawa, S. M. et al. A Nationwide analysis of risk of prostate cancer diagnosis and mortality following an initial negative transrectal ultrasound biopsy with long-term follow-up. J. Urol. 208, 100\u2013108 (2022).","journal-title":"J. Urol."},{"key":"36242_CR13","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3348\/kjr.2018.19.4.733","volume":"19","author":"W Venderink","year":"2018","unstructured":"Venderink, W. et al. Yield of repeat targeted direct in-bore magnetic resonance-guided prostate biopsy (MRGB) of the same lesions in men having a prior negative targeted MRGB. Korean J. Radiol. 19, 733\u2013741 (2018).","journal-title":"Korean J. Radiol."},{"key":"36242_CR14","doi-asserted-by":"publisher","first-page":"897","DOI":"10.21873\/invivo.11556","volume":"33","author":"P Pepe","year":"2019","unstructured":"Pepe, P. et al. Early second round targeted biopsy of PI-RADS score 3 or 4 in 256 men with persistent suspicion of prostate cancer. In Vivo 33, 897\u2013901 (2019).","journal-title":"In Vivo"},{"key":"36242_CR15","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.euo.2021.09.001","volume":"5","author":"J Wallstrom","year":"2022","unstructured":"Wallstrom, J. et al. Prostate cancer screening with magnetic resonance imaging: Results from the second round of the Goteborg prostate cancer screening 2 trial. Eur. Urol. Oncol. 5, 54\u201360 (2022).","journal-title":"Eur. Urol. Oncol."},{"key":"36242_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.urolonc.2021.09.015","volume":"40","author":"F Barletta","year":"2022","unstructured":"Barletta, F. et al. How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series. Urol. Oncol. 40, 103 (2022).","journal-title":"Urol. Oncol."},{"key":"36242_CR17","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/S0022-5347(05)67711-7","volume":"163","author":"B Djavan","year":"2000","unstructured":"Djavan, B. et al. Optimal predictors of prostate cancer on repeat prostate biopsy: A prospective study of 1051 men. J. Urol. 163, 1144\u20131148 (2000) (discussion 1148\u20131149).","journal-title":"J. Urol."},{"key":"36242_CR18","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/j.1464-410X.2012.11607.x","volume":"111","author":"G Ploussard","year":"2013","unstructured":"Ploussard, G. et al. Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: Longitudinal follow-up from a prospective trial. BJU Int. 111, 988\u2013996 (2013).","journal-title":"BJU Int."},{"key":"36242_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clinimag.2018.09.012","volume":"53","author":"SI Hwang","year":"2019","unstructured":"Hwang, S. I. et al. Value of MR-US fusion in guidance of repeated prostate biopsy in men with PSA < 10 ng\/mL. Clin. Imaging. 53, 1\u20135 (2019).","journal-title":"Clin. Imaging."},{"key":"36242_CR20","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet, N. et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur. Urol. 79, 243\u2013262 (2021).","journal-title":"Eur. Urol."},{"key":"36242_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.eururo.2020.03.048","volume":"78","author":"NJ Sathianathen","year":"2020","unstructured":"Sathianathen, N. J. et al. Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and data system era: A systematic review and meta-analysis. Eur. Urol. 78, 402\u2013414 (2020).","journal-title":"Eur. Urol."},{"key":"36242_CR22","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/cncr.33875","volume":"128","author":"HD Patel","year":"2022","unstructured":"Patel, H. D. et al. Risk of prostate cancer for men with prior negative biopsies undergoing magnetic resonance imaging compared with biopsy-naive men: A prospective evaluation of the PLUM cohort. Cancer 128, 75\u201384 (2022).","journal-title":"Cancer"},{"key":"36242_CR23","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/j.juro.2012.08.025","volume":"188","author":"S Vourganti","year":"2012","unstructured":"Vourganti, S. et al. Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J. Urol. 188, 2152\u20132157 (2012).","journal-title":"J. Urol."},{"key":"36242_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.euros.2025.03.006","volume":"75","author":"TFW Soeterik","year":"2025","unstructured":"Soeterik, T. F. W. et al. Personalised prostate cancer diagnosis: Evaluating biomarker-based approaches to reduce unnecessary magnetic resonance imaging and biopsy procedures. Eur. Urol. Open Sci. 75, 106\u2013119 (2025).","journal-title":"Eur. Urol. Open Sci."},{"key":"36242_CR25","first-page":"1","volume":"36","author":"S Remmers","year":"2021","unstructured":"Remmers, S. et al. Reducing biopsies and magnetic resonance imaging scans during the diagnostic pathway of prostate cancer: Applying the Rotterdam prostate cancer risk calculator to the PRECISION trial data. Eur. Urol. Open Sci. 36, 1\u20138 (2021).","journal-title":"Eur. Urol. Open Sci."},{"key":"36242_CR26","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1148\/radiol.2016152542","volume":"280","author":"AB Rosenkrantz","year":"2016","unstructured":"Rosenkrantz, A. B. et al. Interobserver reproducibility of the PI-RADS version 2 Lexicon: A multicenter study of six experienced prostate radiologists. Radiology 280, 793\u2013804 (2016).","journal-title":"Radiology"},{"key":"36242_CR27","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1038\/s41391-021-00444-y","volume":"25","author":"AQ Liu","year":"2022","unstructured":"Liu, A. Q. et al. Initial prostate health index (PHI) and PHI density predicts future risk of clinically significant prostate cancer in men with initial negative prostate biopsy: A 6-year follow-up study. Prostate Cancer Prostatic. Dis. 25, 684\u2013689 (2022).","journal-title":"Prostate Cancer Prostatic. Dis."},{"key":"36242_CR28","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/JU.0000000000000757","volume":"204","author":"MA Pagniez","year":"2020","unstructured":"Pagniez, M. A. et al. Predictive factors of missed clinically significant prostate cancers in men with negative magnetic resonance imaging: A systematic review and meta-analysis. J. Urol. 204, 24\u201332 (2020).","journal-title":"J. Urol."},{"key":"36242_CR29","doi-asserted-by":"publisher","first-page":"13457","DOI":"10.1038\/s41598-023-40371-7","volume":"13","author":"M Kaneko","year":"2023","unstructured":"Kaneko, M. et al. Transperineal vs transrectal magnetic resonance and ultrasound image fusion prostate biopsy: A pair-matched comparison. Sci. Rep. 13, 13457 (2023).","journal-title":"Sci. Rep."},{"key":"36242_CR30","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00345-024-05245-1","volume":"42","author":"M Oderda","year":"2024","unstructured":"Oderda, M. et al. Transrectal versus transperineal prostate fusion biopsy: A pair-matched analysis to evaluate accuracy and complications. World J. Urol. 42, 535 (2024).","journal-title":"World J. Urol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36242-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36242-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36242-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:54:42Z","timestamp":1770368082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-36242-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["36242"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-36242-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5386389\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Seoul National University Bundang Hospital Institutional Review Board (IRB No. B-2410-933-105). It did not involve animal subjects. All procedures followed the ethical standards of the institutional and national research committees and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Due to the retrospective nature of the study, Seoul National University Bundang Hospital Institutional Review Board waived the need of obtaining informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"5202"}}